3 weeks Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment. MarketWatch

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.